Tag: David Loew

Ipsen to acquire American biopharma company Epizyme for $247m

pallavi123- June 27, 2022

French pharma company Ipsen has agreed to acquire Epizyme, a Massachusetts-based commercial-stage biopharma company for an initial consideration of $247 million. Epizyme, which is listed ... Read More

Sanofi announces $396m vaccine manufacturing facility in Toronto

pallavi123- April 15, 2018

French pharma company Sanofi has announced a new vaccine manufacturing facility in Toronto to be built with an investment of CAD500 million ($396.3 million) at ... Read More